Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » News & Analysis

News & Analysis


China biotech company and industry news and analysis...

Recent Articles

  Luye Medical Offers $91 Million for Australian Hospital Chain
  MicuRx Starts China Phase III Trial of Novel Antibiotic
  Tamasek Invests $250 Million in Columbia Pacific for China Hospitals
  Taiwan's TLC Granted Orphan Status in US for Lymphoma Drug
  Zai Lab Acquires Global Rights to Two GSK Anti-Inflammatory Assets
  CFDA Accepts CStone's IND Submission for PD-L1 Candidate
  TOT Breaks Ground on Biologics Production Facility in Suzhou
  Quark and China's GF Securities Form $500 Million Life Science Fund
  Veritas Raises $30 Million from China-Connected Investors for Genetic Tests
  FMD K&L Joins with iMEDGlobal in International CRO Merger


ChinaBio® Events